Xerava Injection, Powder, Lyophilized, For Solution
Product Images NDC 71773-100

3 FDA label images from Tetraphase Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Xerava (NDC 71773-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tetraphase Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Xerava 01)

Chemical Structure (Xerava 01)
Chemical structure of eravacycline dihydrochloride, the active ingredient in Xerava injection powder for solution, depicted as a complex molecular diagram with multiple rings, functional groups, and a fluorine atom.*
FDA Label Image

Principal Display Panel (50 mg Vial Carton)

Principal Display Panel (50 mg Vial Carton)
Packaging label for Xerava (eravacycline) injection, powder, lyophilized for solution, 50 mg per vial. The label indicates it is a single-dose vial, must be reconstituted then diluted for intravenous infusion. The label includes storage instructions, inactive ingredients, and distributor Tetraphase Pharmaceuticals, Inc. The NDC is 71773-050-05.*
FDA Label Image

Principal Display Panel (100 mg Vial Carton)

Principal Display Panel (100 mg Vial Carton)
Packaging label for Xerava (eravacycline) injection, powder, lyophilized for solution, 100 mg per vial. The label specifies it is for intravenous use only, single-dose vial, distributed by Tetraphase Pharmaceuticals, Inc., Waltham, MA. Storage instructions and handling warnings for reconstitution and dilution are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.